KTTA
Pasithea Therapeutics Corp
NASDAQ: KTTA · HEALTHCARE · BIOTECHNOLOGY
$0.69
+0.87% today
Updated 2026-04-30
Market cap
$17.21M
P/E ratio
—
P/S ratio
42.15x
EPS (TTM)
$-2.91
Dividend yield
—
52W range
$0 – $2
Volume
0.4M
WallStSmart proprietary scores
40
out of 100
Grade: D
Sell
Investment rating
6.3
Growth
B5.3
Quality
C+3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
-1.2
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$3.00
+331.84%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 1,498.00% QoQ
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -1.22 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-5.40M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $486559.00 | $486559.00 | $0.00 | $0.00 | $486560.00 |
| Net income | $-13.94M | $-15.96M | $-13.90M | $-20.43M | $-10.11M |
| EPS | — | — | — | — | $-2.91 |
| Free cash flow | $-13.80M | $-13.46M | $-13.92M | $-15.21B | $-5.40M |
| Profit margin | -2,864.29% | -3,280.52% | — | — | — |
Peer comparison
Smart narrative
Pasithea Therapeutics Corp trades at $0.69. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -1.22, it sits in the distress. TTM revenue stands at $486560.00.
Frequently asked questions
What is Pasithea Therapeutics Corp's stock price?
Pasithea Therapeutics Corp (KTTA) trades at $0.69.
Is Pasithea Therapeutics Corp overvalued?
Smart Value Score 40/100 (Grade D, Sell).
What is the price target of Pasithea Therapeutics Corp (KTTA)?
The analyst target price is $3.00, representing +331.8% upside from the current price of $0.69.
What is Pasithea Therapeutics Corp's revenue?
TTM revenue is $486560.00.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-1.22 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio42.15x
ROE-58.40%
Beta0.25
50D MA$0.77
200D MA$0.81
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—